Pig products are used in dentistry; Saliva Orthana (A.S. Pharma) is helpful for some with xerostomia and Mucograft® (Osteohealth®) , that comprises pure porcine collagen, may have a role in selected surgical procedures. Although the focus of this paper is the 'permissibility' or otherwise of vaccines that contain porcinederived components, the Islamic ethical and legal principles that underlie such use are discussed. At the centre of these is istihala, 'changing the impermissible to the permissible through transformation'. An example of this is the changing of wine into vinegar. If the pig product is altered during manufacture, istihala can apply. However, this direction is not consistent across all learned schools. Notwithstanding the tenet of istihala, any prohibition of an 'impermissible' product would fall away if darurah (pl. darurat) can be met -the action is 'permissible' if it preserves life. DOI: 10.1038 DOI: 10. /sj.bdj.2013 
'MEDICALIZING' THE 'HUMAN CONDITION ITSELF'
Community based study of sleep bruxism during early childhood Insana SP, Gozal D et al. Sleep Med 2013; 14: 183-188 It is reported in children, that as the frequency of sleep bruxism increased, so did health problems. These investigators then suggest that sleep bruxism may serve as a 'sentinel marker' for early intervention in order to prevent 'anxious, depressed withdrawn and somatic complaints.' Could the editorial (J Ment Health 2010; 19: 301-304) that explored issues raised by the now recently published DSM-5 (US authority on psychiatric disorders) not offer insight into the above vacuous claim? In this editorial, the authors caution against 'medicalizing' the 'human condition itself'. This retrospective study used data obtained from parental questionnaires obtained from almost five thousand children living in Kentucky. Neurocognitive performance was also assessed. Almost half the children carried out sleep bruxism with a higher prevalence in white than African American children. 
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E-CIGARETTES
BMA calls for stronger regulation of e-cigarettes
A briefing from the Board of Science and the Occupational Medicine Committee (http://bma.org.uk/-/media/Files/PDFs/Working%20for%20 change/Improving%20health/tobaccoecigarettespublicplaces_jan2013.pdf)
It has yet to be shown that 'passive vaping' is harmless. They are brazenly puffed on trains and even within hospital boundaries. E-cigarettes (vapes) are not regulated, although it has recently been announced that from 2016 they will be so by the Medicines and Healthcare Products Regulatory Agency (MHRA). 'NICE will then look again at the use of e-cigarettes'. An e-cigarette consists of a cartridge containing liquid nicotine, a heating element and rechargeable battery. In this briefing paper, it is stated 'there is no peer-reviewed evidence that they (e-cigarettes) are safe or effective…'. In addition, studies have reported that they are used by those who are less motivated to quit smoking and where smoking is banned. Then there is the issue of 'passive vaping'; anabasine, myosmine, and ß-nicotyrine, all putative harmful chemicals, and in half the products the carcinogen nitrosamine, have been identified. DOI: 10.1038 DOI: 10. /sj.bdj.2013 
